Improving gut health through scientifically validated products such as ió Gut Health Drinks (formerly ió fibrewater).

“Interface has been a true catalyst in our journey. Their support helped us secure a pivotal academic partnership that not only validated our product but also opened doors to further studies and global growth. The credibility gained through these collaborations has directly led to investment, award recognition, and market expansion. For any company looking to scale through innovation and evidence, Interface is a game-changer.”

Alyssa Reid, Co-founder, The Prebiotic Company Ltd

Advancement of Product and Technology

Since the successful Asda launch in March 2024, ió fibrewater has evolved into the broader ió Gut Health Drinks brand. The rebrand better reflects the comprehensive health benefits beyond fibre intake, emphasising gut and overall wellbeing.

Building on this, The Prebiotic Company has:

• Reformulated its drinks to feature cleaner labels and fewer ingredients, ensuring optimal efficacy and transparency.
• Developed ió sachets, launching in early 2026, delivering the same scientifically proven gut health benefits in a convenient, portable, sustainable format.
• Secured international growth opportunities, expanding distribution into the EU and US markets.

The Journey

2022-2023 Initial Collaboration – Glasgow Caledonian University (GCU)

Facilitated by Interface, the collaboration with GCU provided the crucial first step in validating the efficacy of their core product, ió fibrewater, and lay the groundwork for future product development. They sought to understand how ió fibrewater impacted different probiotics. As prebiotics feed beneficial microbes (probiotics), the company needed to know exactly how, and what probiotics responded to the core ió fibrewater recipe which would be crucial for expanding their product range.

The project yielded significant findings, released in November 2022 promoting Food Science, academia and industry collaboration. The findings also bolstered investor interest for The Prebiotic Company and paved the way for further collaborations with academic and healthcare institutions.

This collaboration not only provided funding for research but also enriched the academic portfolios of the researchers involved, providing an interdisciplinary project in the fields of microbiology and prebiotic food science.  Additionally, it provided valuable experience for an undergraduate BSc Food Science student to generate preliminary work as part of their final year research project. 

The collaboration also benefited academia through new laboratory methods, expanded bacterial culture collections, and public engagement in food science outreach. These outcomes continue to support ongoing teaching and research initiatives at GCU.

2024-2025 – University of Roehampton, London

Building on the GCU results, The Prebiotic Company partnered with the University of Roehampton to investigate the broader health implications of ió products, specifically their influence on blood glucose regulation, weight management, mood, and sleep. Early results have strengthened scientific credibility and the findings will be published in 2026.

2026 – University of Roehampton, London

A third academic collaboration will begin in January 2026, again with the University of Roehampton, London, focusing on how ió Gut Health Drinks may help reduce the risk of glucose intolerance and Type 2 diabetes in post-menopausal women. This targeted research further demonstrates the company’s commitment to evidence-based innovation and public health impact.

Impact of Academic Collaboration

The Prebiotic Company’s academic collaborations have become a cornerstone of its success having:

• Validated scientific claims, establishing the credibility of ió products in both retail and healthcare markets.
• Accelerated innovation, guiding new product development such as ió sachets and future healthcare applications.
• Enhanced investor confidence, resulting in sustained funding and global growth.
• Strengthened consumer trust, differentiating the brand in a crowded wellness market.
• Provided mutual benefits for academics and students through real-world research, skills development, and public engagement in Food Science.
• Contributed to winning Scottish EDGE funding and the World Best Drink Innovation Award
• Played a direct role in attracting new investment and securing international distribution agreements.
• Together, these achievements position The Prebiotic Company as a leader in the functional drinks and gut health market.

Interface’s Role

Interface has been instrumental throughout The Prebiotic Company’s innovation journey. From the initial introduction to GCU in 2022 to continued advisory support connecting the company with further academic partners.

 Interface has:

• Facilitated access to expertise and facilities essential for scientific validation.
• Supported the translation of research into commercial outcomes, bridging the gap between academia and industry.
• Enabled multi-institution collaborations that underpin ongoing product development and health research.
• Helped raise the company’s profile within Scotland’s innovation ecosystem, contributing to award recognition and funding success.

Looking Ahead

The personal health journeys of the company’s founders Mohsin Laginaf, Alyssa Reid and Jay Curthan continue to drive their commitment to improving gut health for consumers through innovative products.

The Prebiotic Company continues to expand its product range and research base, driven by its founders’ shared mission to improve gut health and wellbeing through evidence-based innovation. With new studies, product formats, and markets on the horizon, the company is poised for sustained impact, supported by a collaborative model that integrates academic excellence, entrepreneurial drive, and Interface’s facilitative expertise.